Dynamix is a venture-backed drug discovery and development company focused on cancer and autoimmune disorders. The company’s platform technology, DynamixFit™, is uniquely suitable for discovering novel small-molecule Type II kinase inhibitors that carry the promise of better clinical profiles. Dynamix has created a pipeline of proprietary novel products, and expects to start clinical development in 2011
| Website | http://www.dynxp.com |
| Employees | 5 (2 on RocketReach) |
| Founded | 2009 |
| Address | Rohovot Business Park 13 Gad Feinstein Rd 3RD L Ste 308, Rehovot 76385, IL |
| Phone | +972 8-939-5010 |
| Technologies | |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Drug Discovery, Manufacturing |
| Keywords | Drug Discovery, Drug Development, Pharmaceutical Research, Biotechnology, Cancer Therapeutics, Oncology, Autoimmune Diseases, Kinase Inhibitors, Small Molecule Drugs, Precision Medicine, Immunology, Clinical Trials, Pharmaceutical, Therapeutics, Drug Pipeline, Life Sciences, Biopharma, Venture Capital, Drug Candidates, New Drug Development |
| Competitors | Johnson & Johnson, Roche, Novartis, AbbVie, Merck & Co., Inc., Pfizer, Sanofi, GSK, Bayer, AstraZeneca +42 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Dynamix Pharmaceuticals employee's phone or email?
2 people are employed at Dynamix Pharmaceuticals.
The NAICS codes for Dynamix Pharmaceuticals are [32541, 32, 3254, 325].
The SIC codes for Dynamix Pharmaceuticals are [28, 283].